Are you Dr. Joubert?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 4 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1275 York Ave
Pathology (5th Floor)
New York, NY 10065Phone+1 212-630-5425- Is this information wrong?
Summary
- Dr. Philippe Joubert, MD is a pathologist in New York, New York. He is currently licensed to practice medicine in Pennsylvania.
Education & Training
University of Montreal Faculty of MedicineClass of 2007
Certifications & Licensure
PA State Medical License 2011 - 2012
Publications & Presentations
PubMed
- 1 citationsExpression of programmed death ligand-1 (PD-L1) in metastatic and postchemotherapy viable testicular germ cell tumors.Mofarej Al-Hogbani, Jérémie Duguay, Daniel-Christoph Wagner, Axel Haferkamp, Philippe Joubert, Sebastian Frees, Ricardo A. Rendon, Nicholas Power, Martine Périgny, Pau...> ;Urologic Oncology. 2021 Mar 5
- 26 citationsComprehensive Assessment of PD-L1 Staining Heterogeneity in Pulmonary Adenocarcinomas Using Tissue Microarrays: Impact of the Architecture Pattern and the Number of Co...Andréanne Gagné, William Enlow, Marc-Antoine Pigeon, Michèle Orain, Stéphane Turcotte, Yohan Bossé, Philippe Joubert> ;The American Journal of Surgical Pathology. 2018 May 1
- 42 citationsPulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations.Natasha Rekhtman, Catherine M. Pietanza, Joshua K. Sabari, Joseph Montecalvo, Hangjun Wang, Omar Habeeb, Kyuichi Kadota, Prasad S. Adusumilli, Charles M. Rudin, Marc L...> ;Modern Pathology. 2018 Jan 1
- Join now to see all
Press Mentions
How AI Can Predict the Recurrence of Lung CancerMarch 21st, 2023
3D Signatures Inc. And L’Institut Universitaire De Cardiologie Et De Pneumologie De Québec (IUCPQ) Announce Collaboration to Combine TeloView™ with Genome Sequence Analysis in Lung CancerMarch 6th, 2018- BioMark to Collaborate with Astrazeneca, Pfizer Canada and the IUCPQ Foundation in a $3.5m Project to Improve Early Detection of Lung CancerDecember 1st, 2021
- Join now to see all
